» Articles » PMID: 23206667

Emotional Valence Modulates Brain Functional Abnormalities in Depression: Evidence from a Meta-analysis of FMRI Studies

Overview
Date 2012 Dec 5
PMID 23206667
Citations 187
Authors
Affiliations
Soon will be listed here.
Abstract

Models describing the neural correlates of biased emotion processing in depression have focused on increased activation of anterior cingulate and amygdala and decreased activation of striatum and dorsolateral prefrontal cortex. However, neuroimaging studies investigating emotion processing in depression have reported inconsistent results. This meta-analysis integrates these findings and examines whether emotional valence modulates such abnormalities. A systematic literature search identified 26 whole-brain and 18 region-of-interest studies. Peak coordinates and effect sizes were combined in an innovative parametric meta-analysis. Opposing effects were observed in the amygdala, striatum, parahippocampal, cerebellar, fusiform and anterior cingulate cortex, with depressed subjects displaying hyperactivation for negative stimuli and hypoactivation for positive stimuli. Anterior cingulate activity was also modulated by facial versus non-facial stimuli, in addition to emotional valence. Depressed subjects also showed reduced activity in left dorsolateral prefrontal cortex for negative stimuli and increased activity in orbitofrontal cortex for positive stimuli. Emotional valence is a moderator of neural abnormalities in depression, and therefore a critical feature to consider in models of emotional dysfunction in depression.

Citing Articles

Engagement and Disengagement: From the Basic Science of Emotion Regulation to an Anxiety Spectrum.

MacNamara A Psychophysiology. 2025; 62(2):e70006.

PMID: 39924448 PMC: 11819891. DOI: 10.1111/psyp.70006.


Cognitive Dysfunction in Unipolar Depression.

Rakesh C , Sharma R, Singh C Indian J Psychol Med. 2024; :02537176241259683.

PMID: 39564278 PMC: 11572421. DOI: 10.1177/02537176241259683.


Functional activity and connectivity signatures of ketamine and lamotrigine during negative emotional processing: a double-blind randomized controlled fMRI study.

Meiering M, Weigner D, Gartner M, Carstens L, Keicher C, Hertrampf R Transl Psychiatry. 2024; 14(1):436.

PMID: 39402015 PMC: 11479267. DOI: 10.1038/s41398-024-03120-6.


Basolateral amygdala parvalbumin and cholecystokinin-expressing GABAergic neurons modulate depressive and anxiety-like behaviors.

Asim M, Wang H, Waris A, He J Transl Psychiatry. 2024; 14(1):418.

PMID: 39368965 PMC: 11455908. DOI: 10.1038/s41398-024-03135-z.


TRPC4/5 inhibitors: Phase I results and proof of concept studies.

Grimm S, Just S, Fuertig R, Dwyer J, Sharma V, Wunder A Eur Arch Psychiatry Clin Neurosci. 2024; .

PMID: 39343822 DOI: 10.1007/s00406-024-01890-0.